(c)
the availability and effectiveness of the veterinary medicinal products in question, and the risks attaching to them;
← art_46__para_2__point_b__point_iv__text_1 · All articles · art_46__para_2__point_c__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-02 · Text as adopted (Official Journal); later amendments are not incorporated in this text.